Clinical Trial Update: An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

View source ↗

Summary

An observational study assessing the burden of upper GI symptoms in patients with cardiovascular risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Disease | Status: COMPLETED